Patrick J. Zenner, Director at SCIELE PHARMA, INC. (SCRX), bought 2,705 shares at $18.46 ($50K) on 2008-03-17, disclosed to the SEC on 2008-03-17.
Open-market purchase of $50k SCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.45 | 1,100 | $20K | 40.6% |
| 2 | $18.46 | 500 | $9K | 18.5% |
| 3 | $18.47 | 400 | $7K | 14.8% |
| 4 | $18.48 | 500 | $9K | 18.5% |
| 5 | $18.49 | 1 | $18 | 0.0% |
| 6 | $18.50 | 204 |
| $4K |
| 7.6% |
| Total | $18.46 avg | 2,705 | $50K | 100% |
| Filing → |
| WST | BUY | 2018-05-17 | $24K | — | Filing → |
| ARQL | BUY | 2018-05-15 | $25K | — | Filing → |
| WST | BUY | 2016-12-09 | $28K | — | Filing → |